Indraprastha Medical Corporation Limited (INDRAMEDCO) AI Stock Analysis

• Market Cap: ₹36.72B
• Dividend Yield: 0.96%
• Average Volume (3M): 33.92K
• Price to Earnings (P/E): 25.1
• Beta (1Y): 1.53
• Revenue Growth: 6.51%
• EPS Growth: 18.24%
• Country: IN
• Employees: 2,977
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 4.80
• Shares Outstanding: 91,673,000
• 10 Day Avg. Volume: 18,340
• 30 Day Avg. Volume: 33,918
• PEG Ratio: 0.75
• Price to Book (P/B): 6.04
• Price to Sales (P/S): 2.66
• P/FCF Ratio: 29.92
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 20.1
• Revenue Forecast (FY): ₹15.63B

• Rating: 64 Neutral
• Price Target: ₹452.00 ▼(-0.89% Downside)
• Action: Reiterated Date: 01/21/26
• Date: Action: Reiterated 01/21/26

The score is supported primarily by strong multi-year financial performance (revenue growth and improving margins) and a solid, low-leverage balance sheet. However, very weak technical momentum (below key moving averages with negative MACD and extremely low RSI/Stoch) and softer 2025 cash flow trends materially reduce the overall rating.

Positive Factors

Multi-year revenue growth

Sustained top-line expansion more than doubled revenue over four years, indicating durable demand for tertiary/quaternary hospital services. This broad revenue base supports reinvestment capacity, scale benefits in procurement and clinician attraction, and underpins medium-term growth prospects.

Negative Factors

Decline in cash balances

Lower cash reserves reduce the company's buffer against cyclical patient volumes or unexpected capex, increasing reliance on operating cash flow and short-term financing. Over 2–6 months this could constrain discretionary spending or delay strategic investments if cash generation weakens further.

Indraprastha Medical Corporation Limited Business Overview & Revenue Model

Company Description

Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of anesthesiology, pediatric, elder care, genomic medicine, health check, sugar, bariatric and metabolic surgery, bone marrow t...

Read more

Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of anesthesiology, pediatric, elder care, genomic medicine, health check, sugar, bariatric and metabolic surgery, bone marrow t...

How the Company Makes Money

INDRAMEDCO generates revenue through several key streams, primarily from the sale of its medical devices and equipment to hospitals, clinics, and healthcare providers. The company may also engage in contracts for supplying medical products to gove...

Read more

INDRAMEDCO generates revenue through several key streams, primarily from the sale of its medical devices and equipment to hospitals, clinics, and healthcare providers. The company may also engage in contracts for supplying medical products to gove...

Indraprastha Medical Corporation Limited Financial Statement Overview

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	14.05B	13.56B	12.45B	10.99B	8.88B	6.13B
Gross Profit	3.81B	3.50B	3.13B	6.25B	4.79B	3.47B
EBITDA	2.78B	2.44B	2.07B	1.61B	1.17B	409.48M
Net Income	1.75B	1.61B	1.24B	861.50M	586.20M	23.30M
Balance Sheet
Total Assets	9.54B	8.52B	7.23B	5.55B	4.62B	4.32B
Cash, Cash Equivalents and Short-Term Investments	4.61B	3.19B	2.24B	1.36B	660.10M	296.10M
Total Debt	313.40M	327.60M	339.50M	24.80M	53.10M	78.18M
Total Liabilities	2.96B	2.55B	2.45B	1.76B	1.36B	1.59B
Stockholders Equity	6.58B	5.97B	4.78B	3.79B	3.25B	2.73B
Cash Flow
Free Cash Flow	808.10M	1.20B	1.31B	998.90M	418.10M	69.35M
Operating Cash Flow	935.10M	1.57B	2.00B	1.44B	712.90M	278.98M
Investing Cash Flow	-1.47B	-1.11B	-1.58B	-1.08B	-511.00M	-201.62M
Financing Cash Flow	-56.60M	-458.80M	-323.80M	-260.40M	-33.70M	-31.47M

Indraprastha Medical Corporation Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 456.05
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:INDRAMEDCO, the sentiment is Positive. The current price of 456.05 is above the 20-day moving average (MA) of 393.35, above the 50-day MA of 393.61, and below the 200-day MA of 459.53, indicating a neutral trend. The MACD of -2.87 indicates Negative momentum. The RSI at 51.61 is Neutral, neither overbought nor oversold. The STOCH value of 54.02 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:INDRAMEDCO.

Indraprastha Medical Corporation Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
PFIZER	69 Neutral	₹223.34B	40.22	―	0.69%	6.13%	35.83%
CONCORDBIO	66 Neutral	₹107.33B	54.58	―	0.80%	3.63%	-1.21%
INDRAMEDCO	64 Neutral	₹36.72B	25.06	―	0.96%	6.51%	18.24%
BIOCON	63 Neutral	₹570.90B	91.56	―	0.12%	10.62%	-66.88%
GLAXO	63 Neutral	₹391.40B	35.44	―	2.16%	4.17%	41.51%
METROPOLIS	61 Neutral	₹87.69B	60.35	―	0.21%	15.41%	5.93%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%